Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD

Abstract Inflammation modifies the incidence and progression of Parkinson’s disease (PD). By using 30 inflammatory markers in CSF in 498 people with PD and 67 people with dementia with Lewy bodies (DLB) we show that: (1) levels of ICAM-1, Interleukin-8, MCP-1, MIP-1 beta, SCF and VEGF were associate...

Full description

Bibliographic Details
Main Authors:	Stefanie Lerche, Milan Zimmermann, Benjamin Roeben, Isabel Wurster, Franca Laura Fries, Christian Deuschle, Katharina Waniek, Ingolf Lachmann, Meike Jakobi, Thomas O. Joos, Thomas Knorpp, Nicole Schneiderhan-Marra, Kathrin Brockmann
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-03-01
Series:	npj Parkinson's Disease
Online Access:	https://doi.org/10.1038/s41531-023-00476-2

Similar Items

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies
by: Kathrin Brockmann, et al.
Published: (2021-10-01)

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
by: Kathrin Brockmann, et al.
Published: (2024-01-01)

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
by: Isabel Wurster, et al.
Published: (2022-09-01)

SWATH Mass Spectrometry-Based CSF Proteome Profile of <i>GBA</i>-Linked Parkinson’s Disease Patients
by: Saima Zafar, et al.
Published: (2022-11-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Secretome Analyses Identify FKBP4 as a <i>GBA1</i>-Associated Protein in CSF and iPS Cells from Parkinson’s Disease Patients with <i>GBA1</i> Mutations
by: Rika Kojima, et al.
Published: (2024-01-01)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
by: Eddie Pradas, et al.
Published: (2023-01-01)

Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma
by: Anna Günther, et al.
Published: (2020-09-01)

Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
by: Idan Rosh, et al.
Published: (2024-02-01)

TDP-43 CSF Concentrations Increase Exponentially with Age in Metropolitan Mexico City Young Urbanites Highly Exposed to PM<sub>2.5</sub> and Ultrafine Particles and Historically Showing Alzheimer and Parkinson’s Hallmarks. Brain TDP-43 Pathology in MMC Residents Is Associated with High Cisternal CSF TDP-43 Concentrations
by: Lilian Calderón-Garcidueñas, et al.
Published: (2022-09-01)

Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system.
by: Serafina Calarco, et al.
Published: (2023-01-01)

GBA mutations and Parkinson's disease in Brazil
by: Carlos R. M. Rieder

Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
by: Jingru Ren, et al.
Published: (2023-02-01)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
by: Seung Pil Yun, et al.
Published: (2018-01-01)

Genetics of Parkinson's disease: Dominant forms and GBA
by: P. Salles, MD, et al.
Published: (2024-07-01)

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
by: Walter Maetzler, et al.
Published: (2016-01-01)

Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease
by: Matteo Senesi, et al.
Published: (2023-02-01)

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic <i>GBA</i> Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
by: Tatiana Usenko, et al.
Published: (2021-09-01)

GBA1 variants in Brazilian Gaucher disease patients
by: Suelen Porto Basgalupp, et al.
Published: (2023-12-01)

Dancing Feet Dyskinesia in a Patient with GBA-PD
by: Diana A. Olszewska, et al.
Published: (2022-01-01)

The Enigmatic Role of GBA2 in Controlling Locomotor Function
by: Marina A. Woeste, et al.
Published: (2017-11-01)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
by: Tapan Behl, et al.
Published: (2021-01-01)

Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
by: Anna Lisa Gündner, et al.
Published: (2019-01-01)

<i>GBA</i> Variants and Parkinson Disease: Mechanisms and Treatments
by: Laura Smith, et al.
Published: (2022-04-01)

The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
by: Lena F. Burbulla, et al.
Published: (2019-12-01)

The clinical outcomes of gut-brain axis (GBA) microbiota influence on psychiatric disordersThe clinical outcomes of gut-brain axis (GBA) microbiota influence on psychiatric disorders
by: Masoumeh Navidinia, et al.
Published: (2023-02-01)

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.
by: Michelle M Mielke, et al.
Published: (2013-01-01)

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson’s Disease: A Pilot Study
by: Ali Yilmaz, et al.
Published: (2020-10-01)

Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients
by: K. Vijayalakshmi, et al.
Published: (2011-03-01)

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
by: Rosie Morris, et al.
Published: (2022-06-01)

Impaired neuron differentiation in GBA-associated Parkinson’s disease is linked to cell cycle defects in organoids
by: Isabel Rosety, et al.
Published: (2023-12-01)

Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system
by: Calarco, S, et al.
Published: (2023)

GBA variants in REM sleep behavior disorder: A multicenter study
by: Krohn, L, et al.
Published: (2020)

Where neurostimulation meets neurodegeneration in Parkinson's disease related to GBA variants
by: Ludy C Shih, et al.
Published: (2024-04-01)

EVALUATING THE ROLE OF SNCA, GBA AND LRRK2 IN THE PATHOGENESIS OF PARKINSON’S DISEASE
by: Alicia Bautista-Garcia, et al.
Published: (2023-10-01)

GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters
by: Carolin Gabbert, et al.
Published: (2023-06-01)

Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis
by: Onal, G, et al.
Published: (2024)

GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
by: Silvia Jesús, et al.
Published: (2016-01-01)

Intelligent Collaborative System Planning Of “City Cluster + Airport Group” In GBA
by: Wang Tian, et al.
Published: (2021-01-01)

Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
by: Sinthuja Pachchek, et al.
Published: (2023-11-01)